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 From a clinical perspective, it is imperative to discern the differences in the 
distribution of virulence factors between imipenem resistant and imipenem susceptible strains 
of uropathogenic Escherichia coli isolated from hospitalized patients. The present study was 
carried out to find this purpose. One-hundred and sixty urine specimens of children and 
seniors were collected from the Educational Hospital of Tehran, Iran. The urine samples were 
cultured immediately and those that were E. coli-positive were analyzed for the antimicrobial 
susceptibility pattern against imipenem using disk diffusion method. Imipenem resistant and 
imipenem susceptible strains were analyzed for the presence of sfa, afa, pap, hly, cnf1 and 
fim virulence factors using the PCR technique. Fifty out of 70 (71.42%) children urines and 55 
out of 90 (61.11%) seniors urine samples harbored E. coli.  The incidence of resistance against 
imipenem in children and seniors were 6% and 9.09%, respectively. In the other hand, 99.39% of 
tested strains were susceptible to imipenem. Total prevalence of pap, cnf1, hly, sfa, afa and fim 
genes in the imipenem resistant strains were 12.5% 25%, 50%, 75%, 62.5% and 25%, respectively. 
Prevalence of the sfa, afa and hly genes was lower in the imipenem susceptible strains of E. 
coli, while the pap, cnf1 and fim genes was entirely higher in the imipenem susceptible strains. 
This finding suggests that imipenem resistance could be directly associated with decreased 
prevalence of pap, cnf1 and fim virulent genes. However, the findings of the present study are 
novel and valuable but more courtesy studies are necessary to authorize them.
Key words: Urpathogenic Escherichia coli, Virulence factors, Imipenem resistant, 
Hospitalized patients, Urinary tract infections.
 Urinary Tract Infections (UTIs) are 
common bacterial infectious diseases causing 
illness in majority of people. The Uropathogenic 
Escherichia coli (E. coli) (UPEC) is one of 
the main etiologic agents for UTIs. It has been 
appraised that the UPEC strains are responsible for 
70-90% of cases of UTIs in children and 40-50% of 
UTIs cases in seniors (Schalger 2001; Riccabona 
2003; Rajan and Prabavathy, 2012). Based on the 
report of World Health Organization (WHO), UTIs 
are determined as a common cause of UTIs in 1% 
of boys and 3–8% of girls (WHO 2005; Foxman 
2003).  
 Treatment is a critical point in the 
epidemiology of UTIs in children and seniors, while 
therapeutic options have become somewhat limited 
because of the presence of multi drug resistant 
strains of UPEC. Imipenem is sometimes the only 
effective agent for treatment of severe UTIs caused 
by multi drug resistant UPEC (Hong et al., 2005). 
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Farshad et al. (2012), Sharmin et al. (2009) and 
Ponnusamy et al. (2012) showed that all strains 
of E. coli isolated from UTIs were sensitive to the 
Imipenem. In E. coli, reports of low-level resistance 
to imipenem are extraordinary, resulting from 
AmpC hyperproduction and loss of porins (Low 
et al., 2001; Nordmann and Poirel, 2002). 
 To appraise the pathogenicity of UPEC 
strains in UTIs, assessment of latent virulence 
factors is requisite. A compulsory state in the 
successful immigration, establishment, and 
ultimately production of infection by UPEC strains 
is an aptitude to adhere to host surfaces such as 
mucous membranes, urinary epithelial or kidney 
tissue. The virulence genes that are most commonly 
associated with UPEC include P fimbriae (pap), 
aerobactin (aer), hemolysin (hly), a fimbrial 
adhesin I (afaI), type 1 fimbria (fim H), cytotoxic 
necrotizing factor 1 (cnf 1) and S fimbriae (sfa) 
(Momtaz et al., 2013; Soto et al., 2009). 
 The sfa gene is responsible for adhesion 
to the endothelial and epithelial cells of the lower 
urinary tract and kidney tissues (Mulvey 2002). The 
cnf1 gene is produced by 1/3 of all pyelonephritis 
strains and may also be involved in kidney 
damages, bladder cell exfoliation and enhancement 
of bacterial access to underlying tissue (Mills et 
al., 2000). The hly gene is associated with upper 
UTIs such as pyelonephritis and also is able to lyses 
nucleated host cell, damage effectors’ immune 
cells, induce the apoptosis of T lymphocytes, 
neutrophils and renal cells, and gain enhanced 
access to host nutrients and iron stores (Bien 
et al., 2012; Los et al., 2013). Clinical findings 
recommend that UPEC strains with afa adhesins 
have characters potentially favoring the occurrence 
of pyelonephritis, recurrent and chronic UTIs (Le 
Bouguénec 2005). 
 T h e r e  w e r e  s e v e r a l  p u b l i s h e d 
investigations showed that resistant strains of 
E. coli are less able to cause upper urinary tract 
infection and have fewer virulence factors than 
susceptible strains (Vila et al., 2002; Farshad et al., 
2010). Some in vitro studies have also suggested 
that decreased pathogenicity of E. coli is associated 
with the acquisition of antibiotic resistance (Vila et 
al., 2002; Piatti et al., 2008; Jadhav et al., 2011). 
Resistant strains of UPEC harbored prosperous and 
diverse amount of virulence factors than susceptible 
strains (Piatti et al., 2008; Jadhav et al., 2011). 
Therefore, it is important to know the differences 
of virulence factors profile between resistant and 
susceptible strains of UPEC. With respect to the 
high importance of imipenem as a best choice for 
treatment of UTIs in Iran, the present study was 
carried out in order to investigate the distribution 
of virulence factors among imipenem resistant and 
imipenem susceptible strains of UPEC isolated 
from hospitalized patients with severe urinary tract 
infections in Iran.
MATERIALS AND METHODS
Samples collection
 From March to December 2012, a total 
of 160 urine samples were collected from children 
(n=70) and seniors (n=90) hospitalized patients 
who suffered from UTIs. Presence of UTIs in 
pediatrics was confirmed using the ultrasound 
technique (MacKenzie et al., 1994). All samples 
were collected from the hospitalized pediatrics 
of Educational Hospital in Tehran, Iran. Most of 
patients had been handling urine catheter for a 
week before they got UTIs. Strong urge to urine 
frequently even immediately after the bladder is 
emptied, painful burning sensation when urinating, 
cloudy and bloody urine with bad smell and in 
some cases fever, chills and nausea are the most 
commonly detected symptoms in patients. In 
order to decrease potential bacterial, and cellular 
contamination, all urine samples were collected 
from midstream. Urine samples were collected 
using the Supra pubic Aspiration (SPA) method 
based on the standard (NICE 2007).
Escherichia coli isolation
 All samples were immediately transferred 
to the Microbiology Research center of the Islamic 
Azad University at 4°C.  Totally, 3 mL of each 
sample was blended with 225 mL of nutrient broth 
(Merck, Germany) for 2 min at normal speed, using 
a Stomacher lab blender and incubated at 37 °C for 
24 h. A 1 mL sample of the nutrient broth culture 
was mixed with 9 mL of MacConkey broth (Merck, 
Germany) and further incubated at 37 °C for 24 h. 
One loop of each tube was streaked on MacConkey 
agar (Merck, Germany). A typical purple colony 
of E. coli was streaked on Eosin Methylene Blue 
agar (EMB agar; Merck, Germany) plate and 
incubated at 37 °C for 24h. Green colonies with a 
metallic luster were considered as typical E. coli 
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colonies. Such colonies were confirmed as E. coli 
using standard biochemical tests (e.g., Methyl red, 
Voges-Proskauer, Indole, and Citrate utilization 
tests). E. coli isolates were stored in Tryptic Soy 
Broth (TSB, Merck, Germany) containing 20% 
glycerol at “70°C for further characterization.
Antimicrobial susceptibility testing
 Pattern of antimicrobial resistance 
was examined using the simple disk diffusion 
technique. The Mueller–Hinton agar (HiMedia 
Laboratories, Mumbai, India, MV1084) medium 
was used for this purpose. Antibiotic resistance 
of E. coli strains against imipenem antibiotic was 
determined using the instruction of Clinical and 
Laboratory Standards Institute guidelines (CLSI 
2012). Susceptibility of E. coli isolates were 
tested against imipenem (30 u/disk) antibiotic 
agent (Oxoid). All of the inoculated plates were 
aerobically incubated at 37 °C for 18-24 h in an 
aerobic atmosphere. Results were interpreted based 
on the instruction provided by CLSI (2012). In all 
reactions, the E. coli ATCC 25922 was used as 
quality control organisms.
DNA extraction and Polymerase Chain Reaction 
(PCR)
 Resistant and susceptible strains of E. 
coli were cultured overnight on Luria-Bertani 
broth (Merck, Germany) and genomic DNA was 
extracted from typical colonies using the DNA 
extraction kit (Fermentase, Germany) according 
to manufacturer’s instruction. Resistant and 
susceptible strains of E. coli were also confirmed 
using the PCR technique (14). A PCR method was 
done with a total volume of 50 µL including 2 mM 
Mgcl
2
, 1 µM of forward primer, 1 µM of reverse 
primer (specified for the 16S rRNA gene of the 
E. coli) (Table 1), 5 µL PCR buffer 10X, 200 µM 
dNTP (Fermentas), 1 U Taq DNA polymerase 
(Fermentas) and 2.5 µL DNA template. The DNA 
was then amplified by 31 successive cycles of 
denaturation at 95°C for 45 s, primer annealing 
at 59°C for 60 s, and DNA chain extension at 
72°C for 60 s. The programmable thermal cycler 
(Eppendorf, Flexercycler2® 5330, Eppendorf-
Netheler-Hinz GmbH, Hamburg,Germany) PCR 
device was used in all PCR reaction.
Detection of UPEC virulence factors
 Several PCR reactions were used for 
detection of virulence factors in imipenem resistant 
and imipenem susceptible strains of E. coli. List 
of primers used for detection of virulence genes 
is shown in Table 1. PCR conditions are shown in 
Table 2. 
 PCR products were electrophoresed 
using 2% agarose gels which was stained with 
ethidium bromide at 90 V for 6 h using 1× TBE 
(0.89 M Tris borate, 0.02 M EDTA, pH 8.3) as the 
running buffer. All products were examined under 
ultraviolet illumination. A set of molecular weight 
standards (Fermentas, GmbH, Germany) ranging 
from 100 bp to 2000 bp was included on each gel. 
In order to confirm the PCR results, the sequencing 
method was used. For this reason, PCR products 
of some positive samples were purified with High 
pure PCR product purification kit (Roche Applied 
Science, Germany) according to manufacturer’s 
recommendations. Single DNA strands were 
sequenced with ABI 3730 XL device and Sanger 
sequencing method (Macrogen, Korea). Result of 
the sequence of each gene was aligned with the 
gene sequences recorded in the GenBank database 
located at NCBI.
Statistical analysis
 The data were analyzed using SPSS 
(Statistical Package for the Social Sciences) 
software and P values were calculated using 
Chi-square and Fisher’s exact tests to identify 
statistically significant relationships for the 
distribution of virulence genes between the 
resistant and susceptible strains of E. coli isolated 
from hospitalized patients with UTIs. A P value < 
0.05 was considered statistically significant.
Ethical issues
 The present study was authorized by the 
ethical committee of the Educational Hospital of 
Tehran, Iran, and the Microbiology and Infectious 
Diseases Center of the Islamic Azad University 
of Shahrekord Branch, Iran. All patients or their 
parents signed the written informed consent.
RESULTS
 All of the urine samples of hospitalized 
children and seniors were examined for E. coli 
using culture and PCR techniques (Figure 1 and 
2). From 160 urine samples, 105 (65.62%) were 
positive for E. coli (Table 3). In addition, 55 out 
of 90 urine samples of seniors (68.75%) and 50 
out of 70 urine samples of children (36.90%) were 
positive for E. coli. There were no significant 
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Table 1. Oligonucleotide primers for detection of various putative virulence 
genes of Uropathogenic Escherichia coli isolated from hospitalized patients
Gene Primer  Primer Sequence (5'-3') Size of  Reference
 name  product (bp) 
pap pap3 GCAACAGCAACGCTGGTTGCATCAT 336 Yamamoto
 pap4 AGAGAGAGCCACTCTTATACGGACA  et al., 1995
cnf1 cnf1 AAGATGGAGTTTCCTATGCAGGAG 498 Yamamoto 
 cnf2 TGGAGTTTCCTATGCAGGAG  et al., 1995
hly hly1 AACAAGGATAAGCACTGTTCTGGCT 1177 Yamamoto 
 hly2 ACCATATAAGCGGTCATTCCCGTCA  et al., 1995
sfa sfa1 CTCCGGAGAACTGGGTGCATCTTAC 410 Le Bouguenec 
 sfa2 CGGAGGAGTAATTACAAACCTGGCA  et al., 1992
afa afa1 GCTGGGCAGCAAACTGATAACTCTC 750 Le Bouguenec 
 afa2 CATCAAGCTGTTTGTTCGTCCGCCG  et al., 1992
fim fim1 GAGAAGAGGTTTGATTTAACTTATTG 559 Struve et al., 
 fim2 AGAGCCGCTGTAGAACTGAGG  1999
Table 2. PCR conditions for detection of virulence genes in 
Uropathogenic Escherichia coli isolated from hospitalized patients
Gene PCR program PCR volume (50 µL)
16srRNA 1 cycle: 5 µL PCR buffer 10X
 95 °C -6 min. 2 mM Mgcl
2
 
31 cycle: 200 µM dNTP (Fermentas)
 95 °C -45 s 1 µM of each primers F & R
 59 °C -60 s 1 U Taq DNA polymerase (Fermentas)
 72 °C -60 s 2.5 µL DNA template
 1 cycle:72 0C -5 min 
fim 1 cycle: 5 µL PCR buffer 10X
 94 °C -3 min. 1.25 mM Mgcl
2
 
40 cycle: 125 µM dNTP (Fermentas)
 94 °C -60 s 0.5 µM of each primers F & R
 58 °C -70 s 1.2 U Taq DNA polymerase (Fermentas)
 72 °C -70 s 3 µL DNA template
 1 cycle: 
 72 °C -6 min 
pap, sfa, afa, 1 cycle: 5 µL PCR buffer 10X
 94 °C -1 min. 1.5 mM Mgcl
2
 
30 cycle: 200 µM dNTP (Fermentas)
hlyA, cnf1 94 °C -60 s 0.4 µM of each primers F & R
 63 °C -30 s 1 U Taq DNA polymerase (Fermentas)
 72 °C -90 s 4 µL DNA template
 1 cycle:72 0C -5 min 
differences in the incidence of E. coli between 
children and seniors. 
 Of 105 isolates of E. coli, 8 strains were 
imipenem resistant (7.61%) (Table 3). We found 
statistically significant (P =0.012) association 
between the incidence of imipenem resistant and 
imipenem susceptible strains of E. coli.
 Distribution of putative virulence 
factors among imipenem resistant and imipenem 
susceptible strains of E. coli is shown in table 4. 
Some different profiles of virulence factors have 
been seen in the imipenem resistant and imipenem 
susceptible strains of E. coli. The most commonly 
detected virulence factors in imipenem resistant 
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Table 3. Distribution of imipenem resistant and imipenem susceptible strains of 
Uropathogenic Escherichia coli isolated from hospitalized patients
Type of urine  No.  No. positive  No. Imipenem  No. Imipenem 
samples samples samples (%) resistant (%*) susceptible (%*)
Seniors 90 55 (61.11) 5 (9.09) 50 (90.91)
Children 70 50 (71.42) 3 (6) 47 (94)
Total 160 105 (65.62) 8 (7.61) 97 (92.39)
*Percentages are based on the positive samples
Table 4. Distribution of putative virulence factors among imipenem resistant and imipenem 
susceptible strains of Uropathogenic Escherichia coli isolated from hospitalized patients
No. positive samples No. positive           Virulence factors (%)
   samples pap cnf1 hly sfa afa fim
Seniors Imipenem resistant 5 1  1  3  4 (80) 3 2 
   (20) (20) (60)   (60) (40)
 Imipenem susceptible 50 23  27 20  25  15  20
   (46)  (54) (40) (50) (30)  (40)
Children Imipenem resistant 3 -  1  1  2  2  -
    (33.33) (33.33) (66.66) (66.66) 
 Imipenem susceptible 47 17  22  12 22 20  19 
   (36.17) (46.80)  (25.53)  (46.80) (42.55) (40.42)
Total Imipenem resistant 8 1  2 (25) 4  6  5  2
   (12.5)  (50) (75) (62.5)  (25)
 Imipenem susceptible 97 41  50  15  47  35  39 
   (42.26) (51.54) (32.98) (48.45) (36.08) (40.20)
strains of E. coli were sfa (75%), afa (62.5%) and 
hly (50%), while cnf1 (51.54%), pap (42.26%) and 
fim (40.20%) were the most commonly detected 
virulence factors in imipenem susceptible strains 
of E. coli (Table 4).
Fig. 1. Gel electrophoresis of PCR products for 
Uropathogenic virulence factors. M: 100bp ladder and 
1-5: positive samples
Fig. 2. Gel electrophoresis of PCR products for fim 
Uropathogenic virulence factors. M: 100bp ladder and 
1: positive samples
 There were significant differences (P 
=0.031) in the incidence of sfa gene between the 
imipenem resistant and imipenem susceptible 
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strains of E. coli, P =0.036 in the incidence of 
afa gene between the imipenem resistant and 
imipenem susceptible strains and P =0.047 in 
the incidence of hly gene between the imipenem 
resistant and imipenem susceptible strains. There 
were significant differences in the incidence of 
cnf1 (P =0.039), pap (P =0.041) and fim (P =0.049) 
genes between imipenem resistant and imipenem 
susceptible strains of E. coli.
DISCUSSION
 The present study specified that 65.62% of 
urine samples of hospitalized patients were infected 
with E. coli. In keeping with this, 7.61% of these 
E. coli strains were resistant to imipenem and it is 
so substantial, while high efficacy of imipenem 
for treatment of UTIs has been reported previously 
from Iran (Farshad et al., 2012; Japoni et al., 2008). 
Higher levels of resistance in E. coli strains against 
imipenem has been reported by Poirel et al. (2004) 
and Martinez-Martinez et al. (2000). Therefore, 
judicious use of antibiotics is required by clinicians.
 The present study showed significant 
assortment in the distribution of virulence 
factors among imipenem resistant and imipenem 
susceptible strains of UPEC. Imipenem resistant 
strains harbored higher amounts of sfa, afa and 
hly factors, while those that were imipenem 
susceptible harbored higher amounts of fim, cnf1 
and pap factors. Contrariwise, the prevalence of the 
sfa, afa and hly genes was lower in the imipenem 
susceptible strains. This finding suggests that 
imipenem resistance could be directly associated 
with decreased prevalence of pap, cnf1 and fim 
virulent genes, as suggested in a previous studies 
(Vila et al., 2002; Farshad et al., 2010). Horcajada 
et al. (2005) reported that nalidixic acid resistance 
strains of E. coli was associated with a significantly 
decreased prevalence of sfa, hly and cnf1 virulence 
factors. It has also been shown by Johnson et al. 
(1988) that the presence of the pap determinants 
was also significantly associated with a lack of 
antimicrobial agent resistance, as it was the case 
with the hly determinants.
 One possible explanation for the high 
prevalence of specific virulence factors in 
imipenem resistant and/or imipenem susceptible 
strains is that E. coli virulence factors are often 
located on plasmids or transposons and these 
virulence factors can be linked to antibiotic 
resistance genes (Boerlin et al., 2005; Travis et 
al., 2006), creating the potential for antimicrobial 
use targeted at UTIs to coselect for virulence 
genes and worsen disease severity. In despite of 
this, there were some previously published data 
showed that susceptible strains of E. coli harbored 
higher amount of virulence factors (Horcajada et 
al., 2005; Rosengren et al., 2009; Vila et al., 2002). 
The extent that imipenem resistant strains of E. coli 
from people with UTIs carries linked virulence 
genes has not been studied extensively. 
 Vila et al., (2002) reported that quinolone-
resistant UPEC strains harbored lower virulence 
factors than susceptible strains. They showed that 
hly and cnf1 factors were less prevalent (P <0.05) 
in nalidixic acid–resistant than in nalidixic acid–
susceptible E. coli strains from patients with either 
pyelonephritis (14.3% vs. 52.4%) or cystitis (0% 
vs. 31.0%). Vila et al., (2002) indicated that among 
E. coli strains causing cystitis, fim expression 
was less prevalent (P <0.05) in the nalidixic 
acid–resistant group (55.2%) than in the nalidixic 
acid–susceptible group (86.2%). Lower prevalence 
of iucD gene was observed among nalidixic acid–
susceptible strains than nalidixic acid–resistant 
strains of UPEC (Vila et al., 2002). It has been 
shown that quinolone resistant UPEC strains 
express fewer virulence factors than quinolone 
susceptible strains (Farshad et al., 2010). 
 According to the studies on the rapport 
between uropathogenic virulence genes which 
have copies on chromosome and plasmid, and 
imipenem sensitivity or resistance, it seems that 
genetic mechanisms related to chromosomes which 
are involved in producing resistance to imipenem 
can induce the expurgation of pathogenicity 
islands (PAIs) genes from chromosome (Bagel et 
al., 1999). On the other hand, genetic relationship 
studies like virulence factors profiling left any 
possibility out for gaining of imipenem resistance 
by E. coli strains that naturally lack these virulence 
factors and then spread in a clonal fashion (Ott 
et al., 1993). Although all premises virtually 
solidly have suggested that becoming resistant to 
antibiotic may affect the absence or presence of 
these factors, another description for this marvel 
might be that some genetic intermediaries involved 
in the expression of virulence genes may conquer 
the expression of the promoter compulsory for 
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resistance to imipenem. Although further studies 
are academically warranted to merge the findings.
 In conclusion, taking into account the 
findings, we propose that cnf1, pap and fim genes 
are predominant in imipenem susceptible strains 
of UPEC. However, more complimentary studies 
in larger groups of UPEC strains are necessary to 
confirm these finding.
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